K223480

Substantially Equivalent

Medipoint Blood Lancets

Applicant: Medipoint Holdings, LLC
Product code: QRK
Advisory panel: General, Plastic Surgery
Date received: 2022-11-18
Decision date: 2023-01-13
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mineola, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.